Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer

Epigenetics

Volumn 8, Issue 12, 2013, Pages 1373-1383

  Yan, Wenji ^a   Wu, Kongming ^b   Herman, James G ^c   Brock, Malcolm V ^c   Fuks, François ^d   Yang, Lili ^e   Zhu, Hongbin ^a   Li, Yazhuo ^a   Yang, Yunsheng ^a   Guo, Mingzhou ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d FREE UNIVERSITY OF BRUSSELS   (Belgium)

^e TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Chemosensitivity; Colorectal cancer; DACH1; DNA methylation; Wnt signaling

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BETA CATENIN; BISULFITE; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; DACHSHUND HOMOLOG 1; DOCETAXEL; MYC PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; CELL VIABILITY; CHEMOSENSITIVITY; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; EPIGENETICS; FEMALE; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME; WESTERN BLOTTING;

CHEMOSENSITIVITY; COLORECTAL CANCER; DACH1; DNA METHYLATION; WNT SIGNALING;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; EPIGENESIS, GENETIC; EYE PROTEINS; FEMALE; GENE SILENCING; HCT116 CELLS; HETEROGRAFTS; HUMANS; MALE; MICE; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION; TAXOIDS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS;

EID: 84888811107     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.26781     Document Type: Article

References (44)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225-49; PMID:19474385; http://dx.doi. org/10.3322/caac.20006
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-917; PMID:21351269; http://dx.doi. org/10.1002/ijc.25516
3. Zhang W, Glöckner SC, Guo M, Machida EO, Wang DH, Easwaran H, Van Neste L, Herman JG, Schuebel KE, Watkins DN, et al. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res 2008; 68:2764-72; PMID:18413743; http://dx.doi. org/10.1158/0008-5472.CAN-07-6349
4. Riojas MA, Guo M, Glöckner SC, Machida EO, Baylin SB, Ahuja N. Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a latestage event in colorectal cancer. Cancer Biol Ther 2007; 6:1710-6; PMID:17986858; http://dx.doi. org/10.4161/cbt.6.11.4829
5. Hanada N, Takahata T, Zhou Q, Ye X, Sun R, Itoh J, Ishiguro A, Kijima H, Mimura J, Itoh K, et al. Methylation of the KEAP1 gene promoter region in human colorectal cancer. BMC Cancer 2012; 12:66; PMID:22325485; http://dx.doi. org/10.1186/1471-2407-12-66
6. Dallosso AR, Øster B, Greenhough A, Thorsen K, Curry TJ, Owen C, Hancock AL, Szemes M, Paraskeva C, Frank M, et al. Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. Oncogene 2012; 31:4409-19; PMID:22249255; http://dx.doi.org/10.1038/onc.2011.609
7. Xu Y, Pasche B. TGF-beta signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet 2007; 16(Spec No 1):R14-20; PMID:17613544; http://dx.doi.org/10.1093/hmg/ddl486
8. Massagué J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103:295-309; PMID:11057902; http://dx.doi. org/10.1016/S0092-8674(00)00121-5
9. Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T, Sakamoto T, Kiyama S, Kiyama Y, Ubai T, et al. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst 2005; 97:1734-46; PMID:16333029; http://dx.doi.org/10.1093/ jnci/dji399
10. Leivonen SK, Ala-Aho R, Koli K, Grénman R, Peltonen J, Kähäri VM. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene 2006; 25:2588-600; PMID:16407850; http://dx.doi.org/10.1038/sj.onc.1209291
11. Leivonen SK, Kähäri VM. Transforming growth factor-beta signaling in cancer invasion and metastasis. Int J Cancer 2007; 121:2119-24; PMID:17849476; http://dx.doi.org/10.1002/ijc.23113
12. Tian M, Schiemann WP. The TGF-beta paradox in human cancer: an update. Future Oncol 2009; 5:259-71; PMID:19284383; http://dx.doi. org/10.2217/14796694.5.2.259
13. Kongkanuntn R, Bubb VJ, Sansom OJ, Wyllie AH, Harrison DJ, Clarke AR. Dysregulated expression of beta-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice. Oncogene 1999; 18:7219-25; PMID:10602475; http://dx.doi.org/10.1038/ sj.onc.1203181
14. Thorstensen L, Lind GE, Løvig T, Diep CB, Meling GI, Rognum TO, Lothe RA. Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia 2005; 7:99-108; PMID:15802015; http://dx.doi.org/10.1593/ neo.04448
15. Van der Flier LG, Sabates-Bellver J, Oving I, Haegebarth A, De Palo M, Anti M, Van Gijn ME, Suijkerbuijk S, Van de Wetering M, Marra G, et al. The Intestinal Wnt/TCF Signature. Gastroenterology 2007; 132:628-32; PMID:17320548; http://dx.doi. org/10.1053/j.gastro.2006.08.039
16. Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 1997; 272:24735-8; PMID:9312064; http://dx.doi. org/10.1074/jbc.272.40.24735
17. Furuhashi M, Yagi K, Yamamoto H, Furukawa Y, Shimada S, Nakamura Y, Kikuchi A, Miyazono K, Kato M. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway. Mol Cell Biol 2001; 21:5132-41; PMID:11438668; http:// dx.doi.org/10.1128/MCB.21.15.5132-5141.2001
18. Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, Cho KW. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 2000; 403:781-5; PMID:10693808; http://dx.doi. org/10.1038/35001602
19. Labbé E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, Moses HL, Attisano L. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res 2007; 67:75-84; PMID:17210685; http://dx.doi.org/10.1158/0008-5472.CAN-06-2559
20. Hussein SM, Duff EK, Sirard C. Smad4 and betacatenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 2003; 278:48805-14; PMID:14551209; http://dx.doi.org/10.1074/jbc. M305472200
21. Letamendia A, Labbé E, Attisano L. Transcriptional regulation by Smads: crosstalk between the TGFbeta and Wnt pathways. J Bone Joint Surg Am 2001; 83-A(Suppl 1):S31-9; PMID:11263663
22. Eger A, Stockinger A, Park J, Langkopf E, Mikula M, Gotzmann J, Mikulits W, Beug H, Foisner R. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene 2004; 23:2672-80; PMID:14755243; http://dx.doi. org/10.1038/sj.onc.1207416
23. Wu K, Li A, Rao M, Liu M, Dailey V, Yang Y, Di Vizio D, Wang C, Lisanti MP, Sauter G, et al. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. Mol Cell Biol 2006; 26:7116-29; PMID:16980615; http://dx.doi. org/10.1128/MCB.00268-06
24. Nan F, Lü Q, Zhou J, Cheng L, Popov VM, Wei S, Kong B, Pestell RG, Lisanti MP, Jiang J, et al. Altered expression of DACH1 and cyclin D1 in endometrial cancer. Cancer Biol Ther 2009; 8:1534-9; PMID:19502783; http://dx.doi.org/10.4161/ cbt.8.16.8963
25. Wu K, Liu M, Li A, Donninger H, Rao M, Jiao X, Lisanti MP, Cvekl A, Birrer M, Pestell RG. Cell fate determination factor DACH1 inhibits c-Juninduced contact-independent growth. Mol Biol Cell 2007; 18:755-67; PMID:17182846; http://dx.doi. org/10.1091/mbc.E06-09-0793
26. Yamada Y, Arao T, Gotoda T, Taniguchi H, Oda I, Shirao K, Shimada Y, Hamaguchi T, Kato K, Hamano T, et al. Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples. Cancer Sci 2008; 99:2193-9; PMID:18957060; http://dx.doi.org/10.1111/j.1349-7006.2008.00935.x
27. Wu K, Yang Y, Wang C, Davoli MA, D'Amico M, Li A, Cveklova K, Kozmik Z, Lisanti MP, Russell RG, et al. DACH1 inhibits transforming growth factorbeta signaling through binding Smad4. J Biol Chem 2003; 278:51673-84; PMID:14525983; http:// dx.doi.org/10.1074/jbc.M310021200
28. Popov VM, Wu K, Zhou J, Powell MJ, Mardon G, Wang C, Pestell RG. The Dachshund gene in development and hormone-responsive tumorigenesis. Trends Endocrinol Metab 2010; 21:41-9; PMID:19896866; http://dx.doi.org/10.1016/j.tem.2009.08.002
29. Kim SS, Zhang RG, Braunstein SE, Joachimiak A, Cvekl A, Hegde RS. Structure of the retinal determination protein Dachshund reveals a DNA binding motif. Structure 2002; 10:787-95; PMID:12057194; http://dx.doi.org/10.1016/S0969-2126(02)00769-4
30. Hammond KL, Hanson IM, Brown AG, Lettice LA, Hill RE. Mammalian and Drosophila dachshund genes are related to the Ski proto-oncogene and are expressed in eye and limb. Mech Dev 1998; 74:121-31; PMID:9651501; http://dx.doi.org/10.1016/ S0925-4773(98)00071-9
31. Sunde JS, Donninger H, Wu K, Johnson ME, Pestell RG, Rose GS, Mok SC, Brady J, Bonome T, Birrer MJ. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. Cancer Res 2006; 66:8404-12; PMID:16951150; http://dx.doi.org/10.1158/0008-5472.CAN-06-0683
32. Zhou B, Liu Y, Kahn M, Ann DK, Han A, Wang H, Nguyen C, Flodby P, Zhong Q, Krishnaveni MS, et al. Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response elementbinding protein (CREB)-binding protein (CBP). J Biol Chem 2012; 287:7026-38; PMID:22241478; http://dx.doi.org/10.1074/jbc.M111.276311
33. Labbé E, Letamendia A, Attisano L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci U S A 2000; 97:8358-63; PMID:10890911; http://dx.doi.org/10.1073/ pnas.150152697
34. Wu K, Katiyar S, Witkiewicz A, Li A, McCue P, Song LN, Tian L, Jin M, Pestell RG. The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth. Cancer Res 2009; 69:3347-55; PMID:19351840; http:// dx.doi.org/10.1158/0008-5472.CAN-08-3821
35. Liang F, Lü Q, Sun S, Zhou J, Popov VM, Li S, Li W, Liu Y, Jiang J, Kong B. Increased expression of dachshund homolog 1 in ovarian cancer as a predictor for poor outcome. Int J Gynecol Cancer 2012; 22:386-93; PMID:22367319; http://dx.doi.org/10.1097/ IGC.0b013e31824311e6
36. Dong Y, Drissi H, Chen M, Chen D, Zuscik MJ, Schwarz EM, O'Keefe RJ. Wnt-mediated regulation of chondrocyte maturation: modulation by TGF-beta. J Cell Biochem 2005; 95:1057-68; PMID:15962307; http://dx.doi.org/10.1002/jcb.20466
37. Minoo P, Li C. Cross-talk between transforming growth factor-beta and Wingless/Int pathways in lung development and disease. Int J Biochem Cell Biol 2010; 42:809-12; PMID:20219694; http:// dx.doi.org/10.1016/j.biocel.2010.02.011
38. Caraci F, Gili E, Calafiore M, Failla M, La Rosa C, Crimi N, Sortino MA, Nicoletti F, Copani A, Vancheri C. TGF-beta1 targets the GSK-3beta/betacatenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res 2008; 57:274-82; PMID:18346908; http://dx.doi.org/10.1016/j.phrs.2008.02.001
39. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of betacatenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275:1787-90; PMID:9065402; http://dx.doi.org/10.1126/ science.275.5307.1787
40. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998; 58:1130-4; PMID:9515795
41. Armand JP. [Focus on cellular pharmacology of docetaxel]. Bull Cancer 2003; 90:1067-70; PMID:14715427
42. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93:9821-6; PMID:8790415; http://dx.doi.org/10.1073/pnas.93.18.9821
43. Jia Y, Yang Y, Liu S, Herman JG, Lu F, Guo M. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma. Epigenetics 2010; 5:743-9; PMID:20716954; http://dx.doi. org/10.4161/epi.5.8.13104
44. Wu K, Yang Y, Wang C, Davoli MA, D'Amico M, Li A, Cveklova K, Kozmik Z, Lisanti MP, Russell RG, et al. DACH1 inhibits transforming growth factorbeta signaling through binding Smad4. J Biol Chem 2003; 278:51673-84; PMID:14525983; http:// dx.doi.org/10.1074/jbc.M310021200